Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05MNV
|
|||
| Former ID |
DIB011680
|
|||
| Drug Name |
Fosclin
|
|||
| Synonyms |
Fosmidomycin + clindamycin (oral, malaria), Jomaa; Fosmidomycin + clindamycin fixed-dose combination (oral, malaria), Jomaa
Click to Show/Hide
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 3 | [1] | |
| Company |
Jomaa Pharma GmbH
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Plasmodium DOXP reductoisomerase (Malaria DXR) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00214643) Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children. U.S. National Institutes of Health. | |||
| REF 2 | Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Dis. 2004 Mar 1;189(5):901-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.